Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma
Clinical trial NCT04802590 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04802590
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-24
- Primary completion
- 2028-03-31
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.